Global siRNA Drugs Supply, Demand and Key Producers, 2023-2029

Page: 79

Published Date: 20 Jan 2023

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global siRNA Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global siRNA Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for siRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of siRNA Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global siRNA Drugs total market, 2018-2029, (USD Million)
Global siRNA Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: siRNA Drugs total market, key domestic companies and share, (USD Million)
Global siRNA Drugs revenue by player and market share 2018-2023, (USD Million)
Global siRNA Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global siRNA Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global siRNA Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Novartis, Sirnaomics and Ribo Life Science, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World siRNA Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global siRNA Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global siRNA Drugs Market, Segmentation by Type
Without GalNAc-conjugated
With GalNAc-conjugated

Global siRNA Drugs Market, Segmentation by Application
Genetic Disease
Cancers
Other

Companies Profiled:
Alnylam
Novartis
Sirnaomics
Ribo Life Science

Key Questions Answered
1. How big is the global siRNA Drugs market?
2. What is the demand of the global siRNA Drugs market?
3. What is the year over year growth of the global siRNA Drugs market?
4. What is the total value of the global siRNA Drugs market?
5. Who are the major players in the global siRNA Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 siRNA Drugs Introduction
    1.2 World siRNA Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World siRNA Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World siRNA Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States siRNA Drugs Market Size (2018-2029)
        1.3.3 China siRNA Drugs Market Size (2018-2029)
        1.3.4 Europe siRNA Drugs Market Size (2018-2029)
        1.3.5 Japan siRNA Drugs Market Size (2018-2029)
        1.3.6 South Korea siRNA Drugs Market Size (2018-2029)
        1.3.7 ASEAN siRNA Drugs Market Size (2018-2029)
        1.3.8 India siRNA Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 siRNA Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 siRNA Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World siRNA Drugs Consumption Value (2018-2029)
    2.2 World siRNA Drugs Consumption Value by Region
        2.2.1 World siRNA Drugs Consumption Value by Region (2018-2023)
        2.2.2 World siRNA Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States siRNA Drugs Consumption Value (2018-2029)
    2.4 China siRNA Drugs Consumption Value (2018-2029)
    2.5 Europe siRNA Drugs Consumption Value (2018-2029)
    2.6 Japan siRNA Drugs Consumption Value (2018-2029)
    2.7 South Korea siRNA Drugs Consumption Value (2018-2029)
    2.8 ASEAN siRNA Drugs Consumption Value (2018-2029)
    2.9 India siRNA Drugs Consumption Value (2018-2029)

3 World siRNA Drugs Companies Competitive Analysis
    3.1 World siRNA Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global siRNA Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for siRNA Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for siRNA Drugs in 2022
    3.3 siRNA Drugs Company Evaluation Quadrant
    3.4 siRNA Drugs Market: Overall Company Footprint Analysis
        3.4.1 siRNA Drugs Market: Region Footprint
        3.4.2 siRNA Drugs Market: Company Product Type Footprint
        3.4.3 siRNA Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: siRNA Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: siRNA Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: siRNA Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: siRNA Drugs Consumption Value Comparison
        4.2.1 United States VS China: siRNA Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: siRNA Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based siRNA Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based siRNA Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies siRNA Drugs Revenue, (2018-2023)
    4.4 China Based Companies siRNA Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based siRNA Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies siRNA Drugs Revenue, (2018-2023)
    4.5 Rest of World Based siRNA Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based siRNA Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies siRNA Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World siRNA Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Without GalNAc-conjugated
        5.2.2 With GalNAc-conjugated
    5.3 Market Segment by Type
        5.3.1 World siRNA Drugs Market Size by Type (2018-2023)
        5.3.2 World siRNA Drugs Market Size by Type (2024-2029)
        5.3.3 World siRNA Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World siRNA Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Genetic Disease
        6.2.2 Cancers
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World siRNA Drugs Market Size by Application (2018-2023)
        6.3.2 World siRNA Drugs Market Size by Application (2024-2029)
        6.3.3 World siRNA Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Alnylam
        7.1.1 Alnylam Details
        7.1.2 Alnylam Major Business
        7.1.3 Alnylam siRNA Drugs Product and Services
        7.1.4 Alnylam siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Alnylam Recent Developments/Updates
        7.1.6 Alnylam Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis siRNA Drugs Product and Services
        7.2.4 Novartis siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Sirnaomics
        7.3.1 Sirnaomics Details
        7.3.2 Sirnaomics Major Business
        7.3.3 Sirnaomics siRNA Drugs Product and Services
        7.3.4 Sirnaomics siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Sirnaomics Recent Developments/Updates
        7.3.6 Sirnaomics Competitive Strengths & Weaknesses
    7.4 Ribo Life Science
        7.4.1 Ribo Life Science Details
        7.4.2 Ribo Life Science Major Business
        7.4.3 Ribo Life Science siRNA Drugs Product and Services
        7.4.4 Ribo Life Science siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Ribo Life Science Recent Developments/Updates
        7.4.6 Ribo Life Science Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 siRNA Drugs Industry Chain
    8.2 siRNA Drugs Upstream Analysis
    8.3 siRNA Drugs Midstream Analysis
    8.4 siRNA Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World siRNA Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World siRNA Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World siRNA Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World siRNA Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World siRNA Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World siRNA Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World siRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World siRNA Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World siRNA Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key siRNA Drugs Players in 2022
    Table 12. World siRNA Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global siRNA Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key siRNA Drugs Player
    Table 15. siRNA Drugs Market: Company Product Type Footprint
    Table 16. siRNA Drugs Market: Company Product Application Footprint
    Table 17. siRNA Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China siRNA Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China siRNA Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based siRNA Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies siRNA Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies siRNA Drugs Revenue Market Share (2018-2023)
    Table 23. China Based siRNA Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies siRNA Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies siRNA Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based siRNA Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies siRNA Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies siRNA Drugs Revenue Market Share (2018-2023)
    Table 29. World siRNA Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World siRNA Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World siRNA Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World siRNA Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World siRNA Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World siRNA Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Alnylam Basic Information, Area Served and Competitors
    Table 36. Alnylam Major Business
    Table 37. Alnylam siRNA Drugs Product and Services
    Table 38. Alnylam siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Alnylam Recent Developments/Updates
    Table 40. Alnylam Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis siRNA Drugs Product and Services
    Table 44. Novartis siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Sirnaomics Basic Information, Area Served and Competitors
    Table 48. Sirnaomics Major Business
    Table 49. Sirnaomics siRNA Drugs Product and Services
    Table 50. Sirnaomics siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Sirnaomics Recent Developments/Updates
    Table 52. Ribo Life Science Basic Information, Area Served and Competitors
    Table 53. Ribo Life Science Major Business
    Table 54. Ribo Life Science siRNA Drugs Product and Services
    Table 55. Ribo Life Science siRNA Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 56. Global Key Players of siRNA Drugs Upstream (Raw Materials)
    Table 57. siRNA Drugs Typical Customers
List of Figure
    Figure 1. siRNA Drugs Picture
    Figure 2. World siRNA Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World siRNA Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World siRNA Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World siRNA Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company siRNA Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. siRNA Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World siRNA Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India siRNA Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of siRNA Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for siRNA Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for siRNA Drugs Markets in 2022
    Figure 27. United States VS China: siRNA Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: siRNA Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World siRNA Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World siRNA Drugs Market Size Market Share by Type in 2022
    Figure 31. Without GalNAc-conjugated
    Figure 32. With GalNAc-conjugated
    Figure 33. World siRNA Drugs Market Size Market Share by Type (2018-2029)
    Figure 34. World siRNA Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World siRNA Drugs Market Size Market Share by Application in 2022
    Figure 36. Genetic Disease
    Figure 37. Cancers
    Figure 38. Other
    Figure 39. siRNA Drugs Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Alnylam
Novartis
Sirnaomics
Ribo Life Science

Related Reports

Global siRNA Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global siRNA Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date New Technology

The siRNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global siRNA Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global siRNA Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Apr 2024

date New Technology

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

Global siRNA Drugs Supply, Demand and Key Producers, 2024-2030

Global siRNA Drugs Supply, Demand and Key Producers, 2024-2030

date 22 Apr 2024

date New Technology

Product Tags

siRNA Drugs

Small Interfering RNA (siRNA) Drugs

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>